CECR2 promotes breast cancer metastasis through NF-kappaB signaling and immunosuppression Feb. 18, 2022
Extracellular domains are not effective targets to disrupt intracellular HER2-HER3 tumor signaling Feb. 18, 2022
Intellia and ONK enter licensing and collaboration agreement for allogeneic NK cell therapies Feb. 17, 2022
BioVaxys reports ACE2 binding inhibition data with haptenized SARS-CoV-2 vaccine BVX-0320 Feb. 17, 2022
RSS